Gene: SLC16A4
Official Full Name: solute carrier family 16 member 4provided by HGNC
Gene Summary: Predicted to enable monocarboxylic acid transmembrane transporter activity. Predicted to be involved in carboxylic acid transmembrane transport. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33557 | SLC16A4 Knockout cell line (HEK293) | Human | SLC16A4 | 1:3~1:6 | Negative | Online Inquiry |
KO33558 | SLC16A4 Knockout cell line (A549) | Human | SLC16A4 | 1:3~1:4 | Negative | Online Inquiry |
SLC16A4 Gene Knockout Cell Lines are specialized cell lines genetically engineered to lack the SLC16A4 gene, which encodes for the transporter protein responsible for the transport of various metabolites, including l-chiral amino acids and neurotransmitters. By creating these knockout models, researchers can investigate the biological functions of SLC16A4 and its role in metabolic processes, neuronal signaling, and potentially its implications in various diseases, including metabolic disorders and neurological conditions.
The key function of these cell lines stems from their ability to regulate intracellular transport mechanisms. By studying the knockout variants, scientists can elucidate the consequences of SLC16A4 absence on cellular metabolism and signal transduction pathways, offering valuable insights into how altered transport functions can affect overall cell health and functionality. This mechanistic understanding is critical for researchers exploring drug metabolism, neurotransmitter transport, and related pharmacogenomics.
In research and clinical settings, SLC16A4 Gene Knockout Cell Lines serve as an invaluable tool for investigating the pathophysiological roles of the SLC16A4 gene. These lines facilitate the development of targeted therapies, contribute to biomarker identification, and accelerate drug discovery processes by providing a relevant model for testing therapeutic candidates and understanding drug-nutrient interactions.
What sets our SLC16A4 Gene Knockout Cell Lines apart from alternatives is their high-quality specification and validation. Each cell line undergoes rigorous quality control to confirm the complete deletion of the SLC16A4 gene, ensuring the reliability and reproducibility of experimental results. Moreover, our cell lines are derived from widely-used parent strains, enabling seamless integration into existing research workflows.
For researchers and clinicians seeking cutting-edge tools to advance their work, SLC16A4 Gene Knockout Cell Lines promise enhanced experimental rigor and novel insights into complex biological systems. Our company has a strong commitment to providing innovative and precise biological products, backed by extensive expertise in molecular biology and genetic engineering, making us a trusted partner in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.